Merck shares drop 10% as pharma giant scraps trial of promising cancer drug
Merck & Co called off a Phase III trial of its promising cancer drug Xevinapant after an independent panel concluded it is unlikely to meet its goals
Coeur Mining announced Friday an agreement in which the gold and silver miner is using its stock, that has more...
Rivian’s stock took a dive Friday, after the electric vehicle maker said it was experiencing a supply shortage, prompting a...
Wall Street has lagged many of its peers in recent months. But that should change.
Wetherspoons chairman Tim Martin hit out at plans aimed at lowering U.K. alcohol consumption
“There is more than enough money in the savings to completely pay off the current mortgage.”
Company says the smallest knock can impact batteries by damaging internal electronics